Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more

oleh: Zhi-Bin Wang, Zhi-Bin Wang, Dan Liu, Guang Lei, Zhao-Qian Liu, Zhao-Qian Liu, Nayiyuan Wu, Nayiyuan Wu, Jing Wang, Jing Wang

Format: Article
Diterbitkan: Frontiers Media S.A. 2023-06-01

Deskripsi

Subjek

ovarian cancer; targeted medication; immunomodulatory; drug resistance; PARP inhibitors; anti-angiogenic drugs